ABEO — Abeona Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00
- $208.17m
- $155.95m
- $3.50m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 129 | 95 | 45 | 52.1 | 52.2 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0 | — | 3 | 0.188 | 2.44 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 132 | 97.7 | 55.4 | 53.1 | 55.7 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 21.2 | 18.4 | 21.7 | 11.1 | 7.99 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 223 | 151 | 79.6 | 64.2 | 64 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 38.7 | 42 | 16.6 | 7.78 | 13.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 45 | 48.6 | 28.2 | 37.5 | 49.2 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 178 | 103 | 51.4 | 26.8 | 14.8 |
Total Liabilities & Shareholders' Equity | 223 | 151 | 79.6 | 64.2 | 64 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |